SCHEMBL23787740

SCHEMBL23787740

Nc1ccc2c(O)c(/N=N/c3ccc(-c4ccc(/N=N/c5c(S(=O)(=O)O)cc6ccc(N)cc6c5O)c(OC(F)(F)F)c4)cc3OC(F)(F)F)c(S(=O)(=O)O)cc2c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PHLPP2 Q6ZVD8 2/20 0.63
▸ ENPP2 Q13822 9/20 0.49
▸ MEN1 O00255 4/20 0.43
▸ KMT2A Q03164 4/20 0.43
▸ KDM4E B2RXH2 3/20 0.43
▸ CYP3A4 P08684 3/20 0.43
▸ THRB P10828 3/20 0.43
▸ HPGD P15428 3/20 0.43
▸ MAPK1 P28482 3/20 0.43
▸ RECQL P46063 3/20 0.43
▸ HSD17B10 Q99714 3/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ TP53 P04637 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ ALOX15 P16050 2/20 0.43
▸ BRCA1 P38398 2/20 0.43
▸ BLM P54132 2/20 0.43
▸ APEX1 P27695 2/20 0.43
▸ TDP1 Q9NUW8 2/20 0.43
▸ SLC10A1 Q14973 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23787588 0.88 PHLPP2 (0.80) PHLPP2ENPP2MEN1KMT2AKDM4E
SCHEMBL23787797 0.86 PHLPP2 (0.56) PHLPP2ENPP2MEN1KMT2AKDM4E
SCHEMBL23787552 0.85 PHLPP2 (0.58) PHLPP2ENPP2MEN1KMT2AKDM4E
SCHEMBL23787647 0.84 PHLPP2 (0.59) PHLPP2ENPP2MEN1KMT2AKDM4E
SCHEMBL23787553 0.82 PHLPP2 (0.61) PHLPP2ENPP2MEN1KMT2AKDM4E
SCHEMBL23787646 0.82 PHLPP2 (0.59) PHLPP2ENPP2MEN1KMT2AKDM4E
SCHEMBL23787555 0.81 PHLPP2 (0.60) PHLPP2ENPP2MEN1KMT2AKDM4E
SCHEMBL23787648 0.80 PHLPP2 (0.59) PHLPP2ENPP2MEN1KMT2AKDM4E
SCHEMBL23787739 0.80 ENPP2 (0.61) PHLPP2ENPP2MEN1KMT2ATHRB
SCHEMBL23787736 0.79 PHLPP2 (0.50) PHLPP2ENPP2MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210275548-A1 NOVEL DNA POLYMERASE GAMMA INHIBITOR AND USES THEREOF ACIBADEM MEHMET ALI AYDINLAR UNIVERSITESI (TR) 2021-09-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210275548-A1 NOVEL DNA POLYMERASE GAMMA INHIBITOR AND USES THEREOF POLG, POLB, POLA1 PHLPP2 1195/4885ENPP2 2691/4885MEN1 2015/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback